| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-08 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |